These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 25686167)

  • 21. The new pooled cohort equations risk calculator.
    Preiss D; Kristensen SL
    Can J Cardiol; 2015 May; 31(5):613-9. PubMed ID: 25843167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.
    Emdin CA; Khera AV; Natarajan P; Klarin D; Baber U; Mehran R; Rader DJ; Fuster V; Kathiresan S
    Am J Cardiol; 2017 Mar; 119(6):881-885. PubMed ID: 28061997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Qureshi WT; Michos ED; Flueckiger P; Blaha M; Sandfort V; Herrington DM; Burke G; Yeboah J
    Am J Cardiol; 2016 Sep; 118(5):691-6. PubMed ID: 27445216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.
    Yeboah J; Young R; McClelland RL; Delaney JC; Polonsky TS; Dawood FZ; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    J Am Coll Cardiol; 2016 Jan; 67(2):139-147. PubMed ID: 26791059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifetime Risks for Hypertension by Contemporary Guidelines in African American and White Men and Women.
    Chen V; Ning H; Allen N; Kershaw K; Khan S; Lloyd-Jones DM; Wilkins JT
    JAMA Cardiol; 2019 May; 4(5):455-459. PubMed ID: 30916719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population.
    Mortensen MB; Nordestgaard BG
    Ann Intern Med; 2018 Jan; 168(2):85-92. PubMed ID: 29297004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment in a preventive cardiology clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk-management gaps among a primary-prevention population compared with a propensity-matched primary-care cohort: A team-based care model and its impact on lipid and blood pressure management.
    Fentanes E; Vande Hei AG; Holuby RS; Suarez N; Slim Y; Slim JN; Slim AM; Thomas D
    Clin Cardiol; 2018 Jun; 41(6):817-824. PubMed ID: 29667200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing Level of Agreement for Atherosclerotic Cardiovascular Disease Risk Categorization Between Coronary Artery Calcium Score and the American College of Cardiology/American Heart Association Cardiovascular Prevention Guidelines and the Potential Impact on Treatment Recommendations.
    Isma'eel H; Min D; Al-Shaar L; Hachamovitch R; Halliburton S; Gentry J; Griffin B; Schoenhagen P; Phelan D
    Am J Cardiol; 2016 Nov; 118(10):1480-1485. PubMed ID: 27642113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study.
    Menon VP; Edathadathil F; Sathyapalan D; Moni M; Don A; Balachandran S; Pushpa B; Prasanna P; Sivaram N; Nair A; Vinod N; Jayaprasad R; Menon V
    Medicine (Baltimore); 2016 Dec; 95(49):e5542. PubMed ID: 27930551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
    Yano Y; O'Donnell CJ; Kuller L; Kavousi M; Erbel R; Ning H; D'Agostino R; Newman AB; Nasir K; Hofman A; Lehmann N; Dhana K; Blankstein R; Hoffmann U; Möhlenkamp S; Massaro JM; Mahabadi AA; Lima JAC; Ikram MA; Jöckel KH; Franco OH; Liu K; Lloyd-Jones D; Greenland P
    JAMA Cardiol; 2017 Sep; 2(9):986-994. PubMed ID: 28746709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
    Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
    Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease.
    Jung KJ; Jang Y; Oh DJ; Oh BH; Lee SH; Park SW; Seung KB; Kim HK; Yun YD; Choi SH; Sung J; Lee TY; Kim SH; Koh SB; Kim MC; Chang Kim H; Kimm H; Nam C; Park S; Jee SH
    Atherosclerosis; 2015 Sep; 242(1):367-75. PubMed ID: 26255683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective Evaluation of ASCVD Risk and Statin Therapy Need in Nondiabetic Patients Based on the 2013 ACC/AHA Cholesterol Guidelines.
    Koenigsfeld C; Sayler M; Smith HL; Meyer K; Lehman N; Logemann C; Bottenberg M; Bryant G; Obermark M
    J Pharm Pract; 2017 Jun; 30(3):300-305. PubMed ID: 27026635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.
    Mora S; Wenger NK; Cook NR; Liu J; Howard BV; Limacher MC; Liu S; Margolis KL; Martin LW; Paynter NP; Ridker PM; Robinson JG; Rossouw JE; Safford MM; Manson JE
    JAMA Intern Med; 2018 Sep; 178(9):1231-1240. PubMed ID: 30039172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
    Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
    JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults.
    Last AR; Ference JD; Menzel ER
    Am Fam Physician; 2017 Jan; 95(2):78-87. PubMed ID: 28084704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts.
    de Las Heras Gala T; Geisel MH; Peters A; Thorand B; Baumert J; Lehmann N; Jöckel KH; Moebus S; Erbel R; Meisinger C; Mahabadi AA; Koenig W;
    PLoS One; 2016; 11(10):e0164688. PubMed ID: 27732641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.